Natural Beauty Bio-Technology Limited
NBBTF
$0.059
-$0.0374-38.80%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 69.03% | 69.62% | 13.41% | 13.20% | -2.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 69.03% | 69.62% | 13.41% | 13.20% | -2.68% |
| Cost of Revenue | 85.33% | 85.98% | 27.81% | 27.58% | -4.43% |
| Gross Profit | 57.96% | 58.51% | 3.96% | 3.77% | -1.45% |
| SG&A Expenses | 5.05% | 5.41% | 25.11% | 24.88% | 21.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 72.45% | 72.38% | 263.57% | 263.30% | -2.52% |
| Total Operating Expenses | 34.36% | 34.83% | 28.48% | 28.24% | 11.22% |
| Operating Income | 187.09% | 187.39% | -1,083.74% | -1,081.93% | -1,163.93% |
| Income Before Tax | 143.51% | 143.67% | -1,283.81% | -1,281.36% | -355.63% |
| Income Tax Expenses | -14.14% | -13.87% | -2,432.26% | -2,424.73% | -42.33% |
| Earnings from Continuing Operations | 135.95% | 136.07% | -1,189.10% | -1,186.42% | -224.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 135.95% | 136.07% | -1,189.10% | -1,186.42% | -224.69% |
| EBIT | 187.09% | 187.39% | -1,083.74% | -1,081.93% | -1,163.93% |
| EBITDA | 366.17% | 367.10% | -166.34% | -166.22% | -243.57% |
| EPS Basic | 140.00% | 140.00% | -1,100.00% | -1,050.00% | -233.33% |
| Normalized Basic EPS | 150.00% | 150.00% | -- | -- | -500.00% |
| EPS Diluted | 140.00% | 140.00% | -1,100.00% | -1,050.00% | -233.33% |
| Normalized Diluted EPS | 150.00% | 150.00% | -- | -- | -500.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |